Eurofins Viracor BioPharma Launches PanCancerIQ Comprehensive Genomic Profiling Service to Advance Precision Oncology Clinical Drug Development
Eurofins Viracor BioPharma Services, a global leader in specialty bioanalytical testing services, announces the launch of their new PanCancerIQ genomic profiling test; a next-generation sequencing (NGS) service that enables comprehensive genomic profiling of tumor samples. In addition to expanding... - March 11, 2021
Press Releases 1 - 1 of 1